Author: Emily Stembridge
Nov. 17, 2021— by Emily Stembridge Troy Chisolm has been named chief operating officer (COO) for Vanderbilt Psychiatric Hospital (VPH). As COO, Chisolm will lead a variety of initiatives and will support exceptional patient service, staff satisfaction, clinical quality outcomes, growth and volume management, and financial performance. “I am so excited to welcome Troy as the new...
Nov. 15, 2021—T. Alp Ikizler, MD, director of Vanderbilt's Division of Nephrology and Hypertension, has been named vice chair for Clinical Research in the Department of Medicine.
Nov. 4, 2021—by Emily Stembridge For many people the practice of gardening represents growth, rebirth and change. When Susan Crawford, RN-BC, a nurse in Vanderbilt Psychiatric Hospital’s (VPH) Intensive Outpatient Programs, realized that these same ideas are also important in the practice of behavioral therapy, she envisioned an initiative to combine the two practices. Crawford’s initiative is...
Nov. 4, 2021—Vanderbilt's Alexander Gelbard, MD, recently detailed the research he and his team completed to better understand idiopathic subglottic stenosis, a rare disease that causes narrowing of the windpipe.
Oct. 28, 2021—Vanderbilt's James Netterville, MD, has been inducted into the American Academy of Otolaryngology–Head and Neck Surgery’s (AAO-HNS) inaugural hall of distinction.
Oct. 21, 2021—by Emily Stembridge Vanderbilt Otolaryngology-Head and Neck Surgery has acquired an SP (single port) surgical robot that will help provide more targeted and accurate transoral robotic surgery (TORS) for patients with head and neck cancer. The new robot features a single port with a flexible camera and three different surgical instruments, as well as an...
Oct. 21, 2021—Vanderbilt's Department of Hearing and Speech Sciences is working to educate clinicians about augmentative and alternative communication methods for patients with communication disorders.
Sep. 30, 2021—A joint project between the Vanderbilt Kennedy Center and the Vanderbilt Center for Cognitive Medicine will help deliver Alzheimer’s disease therapies and treatments to people with Down syndrome (DS).
Sep. 23, 2021—Vanderbilt researchers are studying ways to better evaluate and predict who is at risk of persistent smell and taste loss after COVID-19 infection.